Table 1.
Clinical variable | S0313 (n = 46) | S0014 (n = 60) | S8736 (n = 68) | |||
---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | |
Age, y | ||||||
Median | 61* | 69 | 66 | |||
Range | 23-85 | 26-85 | 35-85 | |||
≥60 | 26 | 57 | 44 | 73 | 52 | 76 |
Male sex | 30 | 65* | 27 | 45 | 40 | 59 |
White race | 43 | 93 | 57 | 95 | 63 | 93 |
Hispanic race | 3 | 7 | 1 | 2 | 2 | 3 |
B symptoms | 9 | 20 | 14 | 23 | 14 | 21 |
Histology | ||||||
DLBCL | 44 | 96 | 56 | 93 | 60 | 88 |
Burkitt-like | 1† | 2 | 3 | 5 | 7 | 10 |
High-grade B | 0 | 0 | 1 | 2 | 1 | 1 |
Mantle cell | 1 | 2 | 0 | 0 | 0 | 0 |
LDH > ULN | 15 | 33 | 13 | 22 | 17 | 25 |
Stage II | 24 | 52 | 26 | 43 | 32 | 47 |
Performance status | ||||||
0 | 29 | 64 | 42 | 70 | 51 | 75 |
1 | 14 | 31 | 17 | 28 | 15 | 22 |
2 | 2 | 4 | 1 | 2 | 2 | 3 |
Stage-modified IPI risk | ||||||
1 | 30 | 65 | 42 | 70 | 40 | 59 |
2 | 12 | 26 | 12 | 20 | 21 | 31 |
3 | 3 | 7 | 6 | 10 | 7 | 10 |
4 | 1 | 2 | 0 | 0 | 0 | 0 |
ULN, upper limit of normal.
Statistically significantly different from study S0014, P < .05.
The only case of Burkitt-like lymphoma in S0313 was reviewed and confirmed to be Burkitt lymphoma.